title: [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
abstract: Rubella is a contagious disease that can be very serious, especially in unvaccinated pregnant women. The best way to be protected is getting vaccinated: MMR vaccine is very effective at protecting people against measles, mumps, and rubella, and preventing the complications caused by these diseases. According to PASSI 2012-2015 (the Italian behavioral risk factor surveillance system) in the territory of ex ASL Roma C only 56% of women between 18 and 49 years were immunized against rubella, thanks to vaccination (34%) or past infection detected by rubeotest (22%); 2% was susceptible and 42% of respondents did not know their immune status against rubella. The Italian National Plan for the Elimination of Measles and Congenital Rubella (PNEMoRc) 2010-15 had the aim to reduce the prevalence of rubella susceptibility in young women (&lt;5%), to reduce the prevalence of congenital rubella and to increase MMR vaccination coverage. This plan suggested to promote actions to spread correct information about MMR vaccine in the general population and healthcare workers and to offer this vaccine to susceptible women during every appropriate contact with the Family planning clinics. In order to ensure and monitor these recommendations, a recovery procedure for MMR vaccine was activated in 2015 for women who contacted the health facilities for their first child vaccination. A form was developed in order to collect information about women's immune status against rubella and measles. According to this tool all women who stated they had never been vaccinated for rubella or MMR and/or did not remember vaccination and/or had never had a rubeotest were considered susceptible to rubella. Women susceptible to rubella were invited to undergo vaccination. Data collected during one year activity were recorded and analyzed with Epinfo 7.0 software. We collected 1801 correctly filled forms; 88.6% (1595) of women were evaluated immune to rubella and 11.4% susceptible. The prevalence of susceptibility seems to be influenced by age, from 16% in the youngest age group to 9% in the &gt;35 years. Among 206 women susceptible to rubella: 38% were vaccinated, 31% preferred to wait, 11% refused vaccination and for 20% data is missing. The protocol of MMR vaccine recovery was effective, and allowed to reach a good number of women who had a contact with the health facilities and we hope this number to be bigger, adding a part of those women who preferred to wait. However, data of a year activity indicate that vaccine recovery initiatives should be proposed and implemented, in consideration of the proportion of rubella susceptibility in women who were recently pregnant.
authors.affiliation: Scuola di Specializzazione in Igiene e Medicina Preventiva, Università degli Studi di Roma "Tor Vergata", Roma, Italia.
authors.forename: Viviana
authors.initials: V
authors.lastname: Santoro
authors.affiliation: Scuola di Specializzazione in Igiene e Medicina Preventiva, Università degli Studi di Roma "Tor Vergata", Roma, Italia.
authors.forename: Valentina
authors.initials: V
authors.lastname: Pettinicchio
authors.affiliation: Distretto Sanitario 12 ex ASL RMC, Roma, Italia.
authors.forename: Andreina
authors.initials: A
authors.lastname: Lancia
authors.affiliation: Servizio Igiene e Sanità Pubblica ex ASL RMC, Roma, Italia.
authors.forename: Cristiana
authors.initials: C
authors.lastname: Vazzoler
authors.affiliation: Servizio Igiene e Sanità Pubblica ex ASL RMC, Roma, Italia.
authors.forename: Francesca
authors.initials: F
authors.lastname: De Luca
authors.affiliation: Dipartimento di Biomedicina e Prevenzione, Università degli Studi di Roma "Tor Vergata", Roma, Italia.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Franco
mesh_terms: D000328:Adult; D005260:Female; D006268:Health Facilities / Q000706:statistics & numerical data*; D006801:Humans; D007558:Italy; D008457:Measles / Q000517:prevention & control*; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage*; D008875:Middle Aged; D009035:Mothers; D009107:Mumps / Q000517:prevention & control*; D011247:Pregnancy; D012384:Rome; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage; D014611:Vaccination / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D022542:Measles-Mumps-Rubella Vaccine; D012411:Rubella Vaccine